REPL

Replimune Group Inc (REPL)

US
$ 7.356.21%

Price Chart

Key Statistics

Market Cap
$ 615.73M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
753.25K
52W High
$ 17.00
52W Low
$ 4.92
Dividend Yield
0.00%
Beta
1.26

Technicals

50-Day MA
11.1015
200-Day MA
11.3018
52 Week High
17
52 Week Low
4.92

About REPL

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer.

Employees
331
Headquarters
Woburn, MA
CEO
Mr. Philip Astley-Sparke F.S.A.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
SMX
SMX (Security Matte...
$ 2.30
57.53
HTZ
Hertz Global Holdin...
$ 7.70
34.85
CAR
Avis Budget Group I...
$ 84.00
15.45
LLY
Eli Lilly and Compa...
$ 844.40
14.93
LAZR
Luminar Technologie...
$ 3.77
13.21

Top Losers

Symbol/Name
LTP
% Chg
UNH
UnitedHealth Group ...
$ 454.75
-22.32
MLGO
MicroAlgo Inc. Ordi...
$ 6.84
-18.40
TGL
Treasure Global Inc...
$ 3.12
-18.11
FFIV
F5 Inc. Common Stock
$ 258.61
-13.51
IBO
IBO (Listing Market...
$ 0.40
-8.47